Orexo AB (publ) (OM: ORX)
Health Care · Pharmaceuticals · SE
Skr6.19
-5.93% today · -83.9% 1Y
Orexo AB (publ) (OM: ORX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.32M and employs 61 people.
Over the last twelve months the share price has lost 83.9%, trading between 6.30 and 43.40.
Tweenvest scores Orexo AB (publ) across four factors: quality 61/100, value 49/100, growth 0/100. Its strongest factor is quality.
ORX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.32M
- Revenue (TTM)
- $1.71M
- P/E
- —
- EPS
- 13.24
- Dividend yield
- —
- Beta (5Y)
- 0.86
- 52-week high
- Skr43.40
- 52-week low
- Skr6.30
- Avg volume (3M)
- —
- Shares outstanding
- 36.95M
- Employees
- 61
- Next earnings
- —
About Orexo AB (publ)
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
- ISIN
- SE0000736415
- Founded
- 1994
- Listed since
- Nov 9, 2005
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cilo Cybin Holdings LimitedJSE: CCC | $25.26M | R1.45 | -2.68% |
| MedRx Co., LtdTSE: 4586 | $25.10M | ¥58.00 | -1.69% |
| Yung Zip Chemical Ind. Co., Ltd.TPEX: 4102 | $24.91M | NT$18.80 | +1.90% |
| iAnthus Capital Holdings, Inc.CNSX: IAN | $24.44M | CA$0.01 | -50.00% |
| Everest Organics LimitedBSE: 524790 | $24.15M | Rs240.65 | +9.49% |
| Gennex Laboratories LimitedBSE: 531739 | $24.12M | Rs9.61 | -1.94% |
| PT Indofarma TbkIDX: INAF | $23.91M | Rp— | — |
| TherapeuticsMD, Inc.NasdaqGS: TXMD | $23.84M | $2.02 | -1.94% |
Figures last refreshed Oct 11, 2026.